Extrait

1) To evaluate the efficacy of glufosfamide in subjects with metastatic pancreatic adenocarcinoma previously treated with gemcitabine as measured by overall survival compared with best supportive care 2) To evaluate the safety of glufosfamide in subjects with metastatic pancreatic adenocarcinoma previously treated with gemcitabine

Critère d'inclusion

• Previously treated metastatic pancreatic adenocarcinoma

Liens

• ictrp
• euctr